Comparison of clinical and molecular characteristics of patients with acute myeloid leukemia and either TP73 or TP53 mutations
      QxMD      Google Scholar   
Citation:
Leukemia vol 35 (4) 1188-1192
Year:
2021
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
10
Parents:
2992  
Children:
None
Program:
TRP
Primary Committee:
Leuk Corr Sci
Sec. Committees:
   
Pharmas:
 
Grants:
CA233338, CA101140, CA140158, CA180861, CA196171, CA016058, CA180821, CA180882, CA077658, U24CA196171  
Corr. Author:
 
Authors:
                             
Networks:
LAPS-MA036, LAPS-OH007, NC002, NORTHWELL, OH070   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-20202, CALGB-8461, CALGB-9665
Phases:
N/A
Keywords:
acute myeloid leukemia, TP73 , TP53 , mutation